Belov, V., Guehl, N. J., Duvvuri, S., Iredale, P., Moon, S.-H., Dhaynaut, M., Chakilam, S., MacDonagh, A. C., Rice, P. A., Yokell, D. L., Renger, J. J., El Fakhri, G., & Normandin, M. D. (2024). PET imaging of M4 muscarinic acetylcholine receptors in rhesus macaques using [11C]MK-6884: Quantification with kinetic modeling and receptor occupancy by CVL-231 (emraclidine), a novel positive allosteric modulator. Journal of Cerebral Blood Flow & Metabolism, 44(8), 1329–1342. https://journals.sagepub.com/doi/10.1177/0271678X241238820
Bodick, N. C., Offen, W. W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., Shannon, H. E., Tollefson, G. D., Rasmussen, K., Bymaster, F. P., Hurley, D. J., Potter, W. Z., & Paul, S. M. (1997). Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease. Archives of Neurology, 54(4), 465–473. https://jamanetwork.com/journals/jamaneurology/article-abstract/594526
Duvvuri, S., Iredale, P., Belov, V., Guehl, N., Moon, S.-H., & Dhaynaut, M. (2021). Evaluation of M4 Muscarinic Receptor Occupancy by CVL-231 Using [11C]MK-6884 PET in Non-Human Primates. https://pmc.ncbi.nlm.nih.gov/articles/PMC11342722/
Duvvuri, S., Iredale, P., Pin, S., Smith, D., Zhang, J., Giugliano, A., & Koole, M. (2024, April). Evaluation of M4 Muscarinic Receptor Occupancy by Emraclidine Using [11C]MK-6884 PET in Healthy Volunteers. 2024 Annual Congress of the Schizphrenia Society. https://pubmed.ncbi.nlm.nih.gov/38477292/
Gollapelli, K. K., Krizan, I., Bhoopal, B., Damuka, N., Moriarty, C., Miller, M., Sai, K. K. S., & Gould, R. W. (2025). [11C]MK-6884 PET imaging reveals lower M4 muscarinic acetylcholine receptor availability following cocaine self-administration in male rats. Pharmacological Reports, 77(2), 532–541. https://link.springer.com/article/10.1007/s43440-025-00695-9
Li, W., Wang, Y., Lohith, T. G., Zeng, Z., Tong, L., Mazzola, R., Riffel, K., Miller, P., Purcell, M., Holahan, M., Haley, H., Gantert, L., Hesk, D., Ren, S., Morrow, J., Uslaner, J., Struyk, A., Wai, J. M.-C., Rudd, M. T., … Basile, A. S. (2022). The PET tracer [11C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer’s disease. Science Translational Medicine, 14(627). https://pubmed.ncbi.nlm.nih.gov/35020407/
Marin, T., Belov, V., Chemli, Y., Ouyang, J., Najmaoui, Y., Fakhri, G. E., Duvvuri, S., Iredale, P., Guehl, N. J., Normandin, M. D., & Petibon, Y. (2025). PET Mapping of Receptor Occupancy Using Joint Direct Parametric Reconstruction. IEEE Transactions on Biomedical Engineering, 72(3), 1057–1066. https://pubmed.ncbi.nlm.nih.gov/39446540/
Masdeu, J., Pascual, B., Zanotti-Fregonara, P., Yu, M., Funk, Q., Arbones, V., Rockers, E., Wang, Y., Li, W., Cheng, A., Anderson, M., Hostetler, E., & Basile, A. (2020). [11C]MK-6884 PET Tracer for M4 Muscarinic Cholinergic Receptors in Alzheimer’s Disease: Comparison with [18F]FDG PET (2640). Neurology, 94(15_supplement), 2640. https://www.neurology.org/doi/10.1212/WNL.94.15_supplement.2640
Pascual, B., Zanotti-Fregonara, P., Yu, M., Funk, Q., Arbones, V., Wang, Y., Li, W., Cheng, A., Anderson, M., Hostetler, E., Basile, A., & Masdeu, J. (2021). [11C]MK-6884 PET Tracer for M4 Muscarinic Cholinergic Receptors in Alzheimer’s Disease: Comparison with [18F]FDG PET (4241). Neurology, 96(15_supplement), 4241. https://www.neurology.org/doi/10.1212/WNL.96.15_supplement.4241
Shekhar, A., Potter, W. Z., Lightfoot, J., Lienemann, J., Dubé, S., Mallinckrodt, C., Bymaster, F. P., McKinzie, D. L., & Felder, C. C. (2008). Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia. American Journal of Psychiatry, 165(8), 1033–1039. https://psychiatryonline.org/doi/10.1176/appi.ajp.2008.06091591
Tong, L., Li, W., Lo, M. M.-C., Gao, X., Wai, J. M.-C., Rudd, M., Tellers, D., Joshi, A., Zeng, Z., Miller, P., Salinas, C., Riffel, K., Haley, H., Purcell, M., Holahan, M., Gantert, L., Schubert, J. W., Jones, K., Mulhearn, J., … Mazzola, R. (2020). Discovery of [11 C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases. Journal of Medicinal Chemistry, 63(5), 2411–2425. https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01406
Collaborators Login